Priya Koppikar
The University of Texas MD Anderson Cancer Center(US)The University of Texas MD Anderson Cancer Center(US)
Publications by Year
Research Areas
Cytokine Signaling Pathways and Interactions, Myeloproliferative Neoplasms: Diagnosis and Treatment, Chronic Myeloid Leukemia Treatments, Acute Myeloid Leukemia Research, Chronic Lymphocytic Leukemia Research
Most-Cited Works
- → Heterodimeric JAK–STAT activation as a mechanism of persistence to JAK2 inhibitor therapy(2012)362 cited
- → JAK–STAT Pathway Activation in Malignant and Nonmalignant Cells Contributes to MPN Pathogenesis and Therapeutic Response(2015)306 cited
- → JAK2V617F-Mediated Phosphorylation of PRMT5 Downregulates Its Methyltransferase Activity and Promotes Myeloproliferation(2011)261 cited
- → HSP90 is a therapeutic target in JAK2-dependent myeloproliferative neoplasms in mice and humans(2010)179 cited
- → CHZ868, a Type II JAK2 Inhibitor, Reverses Type I JAK Inhibitor Persistence and Demonstrates Efficacy in Myeloproliferative Neoplasms(2015)152 cited
- → Targeting megakaryocytic-induced fibrosis in myeloproliferative neoplasms by AURKA inhibition(2015)140 cited